Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: 500ml 6% Pentastarch: Single Infusion
Control Intervention1: 1000 ml Ringerâ??s lactate: Single Infusion
Sponsors
Dr Yoganarasimha N
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to give informed consent. 2. ASA 2 patients. 3. Pregnant females at term. 4. With uncomplicated pregnancies. 5. Elective LSCS. 6. Height of the patient between 150 - 170 cms.
Exclusion criteria
Exclusion criteria: 1. Unstable haemodynamic, cardiovascular insufficiency or fixed cardiac output states. 2. Hypertensive disorders of pregnancy, diabetes mellitus or other causes of peripheral neuropathy and autonomic dysfunction. 3. Pregnant ladies with foetal anomalies and twin gestation. 4. Known history of allergy to local anaesthetics or study drugs. 5. Patients with coagulation abnormalities, or on anticoagulants. 6.Features of soft tissues infection at the site of sub arachnoid block. 7. Chronic/essential hypertension, vasculitis/vascular disorder. 8. Contraindications to sub arachnoid block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the vasopressor requirement in both the groupsTimepoint: 0 to 10 minutes after SAB and at 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, 35 minutes, 40 minutes, 45 minutes, 50 minutes, 55 minutes, 60 minutes of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Safety of the drugsTimepoint: 0 to 10 minutes after SAB and at 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, 35 minutes, 40 minutes, 45 minutes, 50 minutes, 55 minutes, 60 minutes of surgery | — |
Countries
India
Contacts
Public ContactDr Kiran Kumar O
BGS Global Institute of Medial Sciences
Outcome results
None listed